The hypertension-based chronic disease model in a primary care setting

Eduardo Thadeu de Oliveira Correia1,2, Jeffrey I Mechanick3, Antonio José Lagoeiro Jorge2

  • 1Department of Radiology, University Hospitals Cleveland Medical Center, Cleveland, OH, USA.

Insights

The novel Hypertension-Based Chronic Disease (HBCD) model effectively categorizes cardiometabolic risk. Higher HBCD stages correlate with poorer health outcomes, including increased mortality and cardiovascular events.

Area of Science:

  • Cardiology
  • Nephrology
  • Public Health

Background:

  • Cardiometabolic risk is a significant public health challenge.
  • Existing driver-based chronic disease models lack data on the novel Hypertension-Based Chronic Disease (HBCD) model.
  • This study addresses the need for data on HBCD model prevalence, characteristics, and prognostic significance.

Purpose of the Study:

  • To investigate the prevalence and characteristics of the Hypertension-Based Chronic Disease (HBCD) model.
  • To assess the prognostic significance of HBCD Stages in a primary care cohort.
  • To validate the HBCD model as a tool for understanding cardiometabolic risk progression.

Main Methods:

  • A cohort of 633 primary care participants (aged ≥45) in Brazil was randomly selected.
  • Participants underwent electrocardiogram and tissue Doppler echocardiogram.
  • Participants were classified into HBCD Stages (1-4) and followed for a median of 6 years for prognostic analysis.

Main Results:

  • Prevalence: 1.3% no risk factors, 10.0% Stage 1, 14.7% Stage 2, 51.5% Stage 3, 22.5% Stage 4.
  • Worsening HBCD stages correlated with poorer kidney function, adverse echocardiographic markers, higher BMI, and increased type 2 diabetes prevalence.
  • All-cause mortality or cardiovascular hospitalization rates increased significantly across HBCD Stages (Stage 1: 3.6% to Stage 4: 39.5%).

Conclusions:

  • The Hypertension-Based Chronic Disease (HBCD) model is conceptually and prognostically valid.
  • HBCD stages are significantly associated with worsening cardiac and kidney health markers.
  • The HBCD model predicts increased risk of mortality and cardiovascular hospitalization.
Abstract

Related Concept Videos

Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
16
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
25
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
11
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
2.1K
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
14
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage kidney disease (ESKD). At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate...
34